- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: mirabegron
Total 167 results
-
Astellas Scientific & Medical Affairs, Inc.CompletedUrologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Canada
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of MirabegronUnited States
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesBelgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
-
Buddhist Tzu Chi General HospitalUnknownOveractive Bladder SyndromeTaiwan
-
Université de SherbrookeCompleted
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
-
CHU de Quebec-Universite LavalCompletedOveractive Bladder | Urinary Incontinence
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...CompletedOveractive BladderBangladesh
-
CHU de Quebec-Universite LavalCompletedOveractive Bladder | Urinary Incontinence
-
Astellas Pharma IncCompletedOveractive BladderJapan
-
Samsung Medical CenterCompleted
-
Astellas Pharma IncCompleted
-
Seoul National University HospitalUnknownOveractive Bladder | Parkinson DiseaseKorea, Republic of
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder, Overactive | Urinary Bladder DiseasesGreece, Ireland, Armenia, Austria, Belarus, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Hungary, Italy, Kazakhstan, Latvia, Lebanon, Lithuania, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovaki... and more
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States, Canada
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveAustralia, Belgium, France, Spain, Sweden, Bulgaria, Romania, Italy, Greece, South Africa, Austria, Poland, United Kingdom, Hungary, Denmark, Netherlands, Switzerland, Ireland, Lithuania, Russian Federation, Germany, Latvia, Slovakia, Finlan... and more
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveCanada, Poland, Belgium, Spain, Sweden, United States, Romania, Italy, France, Austria, United Kingdom, Germany, Hungary, Australia, Denmark, Netherlands, Switzerland, Lithuania, Russian Federation, Latvia, South Africa, Slovakia, F... and more
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States, Hungary, Canada, Spain, Finland, Slovakia, Czechia, Sweden, Germany, Denmark, Norway
-
Università degli Studi di BresciaCompleted
-
Otto MuzikUnknownBrown FatUnited States
-
Buddhist Tzu Chi General HospitalCompletedUrinary Incontinence | Overactive Bladder Syndrome
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, Czech Republic, Germany, Spain, Sweden, United Kingdom
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveChina, Taiwan, India, Korea, Republic of
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveJapan
-
Buddhist Tzu Chi General HospitalUnknownOveractive Bladder SyndromeTaiwan
-
Astellas Pharma IncCompleted
-
Fundación Centro Nacional de Investigaciones Cardiovasculares...Hospital Clinic of Barcelona; Fundació Institut de Recerca de l'Hospital de... and other collaboratorsUnknownHeart Failure | Pulmonary Hypertension | Mirabegron | Pulmonary Vascular Resistance Abnormality
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveJapan
-
Karolinska InstitutetCompletedOveractive BladderSweden
-
Astellas Pharma IncCompletedOveractive Bladder | Cardiovascular DiseaseJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma Europe B.V.Completed
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of YM178United States
-
American Society Of Thermalism And Climatology IncUnknownPrimary Open Angle Glaucoma | Hypertension OcularUnited States
-
Seoul National University HospitalUnknown
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Drug-Drug Interaction (DDI)Germany
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Drug-Drug Interaction (DDI)Germany
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of MirabegronNetherlands
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of MirabegronFrance
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Canada
-
Astellas Pharma Europe B.V.Completed
-
Astellas Pharma IncCompletedIntraocular PressureUnited States
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics | CardiovascularUnited Kingdom
-
Astellas Pharma IncCompletedPost-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of TolterodineHealthy | Pharmacokinetics of Mirabegron and TolterodineJapan
-
Astellas Pharma IncCompletedRenal ImpairmentUnited States
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Mild and Moderate Hepatic ImpairmentSlovakia
-
Astellas Pharma Europe B.V.Completed
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of MirabegronFrance